Web8.24.4.3.1 Cisplatin. Cisplatin, a platinum analogue, is an alkylating agent used in combination with other agents to treat a variety of solid malignancies, including lung cancer, head and neck cancer, mesothelioma, ovarian cancer, and bladder cancer. It is also used prior to bone marrow and stem cell transplantation. WebAlex Ocampo (2014 -2024) Latest Position: Principal Statistician, Novartis Isabel Fulcher (2014-2024) Current Position: Postdoctoral Fellow, Harvard Data Science Initiative Jaffer Zaidi (2014-2024…
肾衰可能是吃出来的-何坤-中文期刊【掌桥科研】
WebJun 18, 2024 · Rationale: The use of cisplatin in patients with chronic kidney disease (CKD) is risky and depends on a number of factors. The optimal procedure in stage I of a non seminomatous germ cell tumor without proven lymphangioinvasion after orchiectomy is controversial and is the subject of a number of discussions due to the lack of randomized … WebFigure 2. Outcomes in Patients with Standard-Risk Hepatoblastoma Who Received Cisplatin Alone versus Cisplatin plus Doxorubicin. The response rate was 90% in the cisplatin … first united methodist church of stuart
The effect of different doses of cisplatin on the pharmacokinetic ...
WebPaul completed a BSc (Hons) in Immunology as a University of Glasgow undergraduate and a PhD investigating the associations of inflammatory biomarkers with CVD under Prof Gordon L WebSep 4, 2024 · Cisplatin is a powerful drug used in some chemotherapy treatments to treat many forms of cancer. Cisplatin and similar platinum-based drugs are prescribed for an … Webcisplatin and for at least 26weeks following the last dose. Men with female partners of childbearing potential should be advised to use effective contraception during treatment with cisplatin and for at least 14weeks after the last dose. For patients with end-stage renal disease, the washout period of cisplatin will be longer (up to first united methodist church of san diego